Skip to main content
. Author manuscript; available in PMC: 2013 Apr 18.
Published in final edited form as: Oncogene. 2011 Dec 5;31(42):4559–4566. doi: 10.1038/onc.2011.539

Figure 3. Differential Gene Expression in KRAS-variant (KV) EOC Tumors.

Figure 3

A. A signature of 50 differentially expression gene candidates in KV triple negative breast tumors15 shows higher scores in KV EOC samples than in non-variant samples. B. Genes associated with KRAS-addicted tumors20 were used to create a corresponding signature, which is up-regulated in KV EOC tumors. C. Re-analysis of differential gene expression in carboplatin-sensitive and resistant EOC cells21 shows differential expression of the top 20 genes in KV EOC tumors. D. Top differentially expressed genes between KV (green) and non-variant (blue) tumor samples.